Summary
Given the lack of proven efficacy of conventional therapies, it is not surprising that patients have turned with increasing frequency to phytotherapy and other alternative treatments. Although alternative therapies are plentiful, few have been subjected to scientific scrutiny and prospective controlled clinical trials. This chapter will cover therapies commonly used in prostatitis patients and focus in detail on those with published data. These treatments include zinc, cernilton (bee pollen), quercetin, and saw palmetto. Complementary therapies may indeed have much to offer patients, particularly those with chronic degenerative conditions in which allopathic therapies have proven less successful. Alternative therapies, however, require the same scientific criteria for validation and acceptance as do conventional medical therapies.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ulbricht, C., Basch, E., Weissner, W., Hackman, D. (2006) An evidence-based systematic review of herb and supplement interactions by the Natural Standard Research Collaboration. Expert Opin. Drug Saf. 5, 719–728.
Hilliard, J. J., Krause, H. M., Bernstein, J. I., et al. (1995) A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyrase. Adv. Exp. Med. Biol. 390, 59–69.
Bernard, F. X., Sable, S., Cameron, B., et al. (1997) Glycosylated flavones as selective inhibi tors of topoisomerase I V. Antimicrob. Agents Chemother. 41, 992–998.
Heczko, P. B., Strus, M., and Kochan, P. (2006) Critical evaluation of probiotic activity of lactic acid bacteria and their effects. J. Physiol. Pharmacol. 57(Suppl 9), 5–12.
Huebner, E. S., and Surawicz, C. M. (2006) Probiotics in the prevention and treatment of gastrointestinal infections. Gastroenterol. Clin. North Am. 35, 355–365.
Kavanagh, J. P., Darby, C., and Costello, C. B. (1982) The response of seven prostatic fluid components to prostatic disease. Int. J. Androl. 5, 487–496.
Fair, W. R., Couch, J., and Wehner, N. (1976) Prostatic antibacterial factor. Identity and significance. Urology 7, 169–177.
Fahim, M. S., Ibrahim, H. H., Girgis, S. M., Essa, H. A., and Hanafi, S. (1985) Value of intrap-rostatic injection of zinc and vitamin C and of ultrasound application in infertile men with chronic prostatitis. Arch. Androl. 14, 81–87.
Neal, D. E., Jr., Kaack, M. B., Fussell, E. N., and Roberts, J. A. (1993) Changes in seminal fluid zinc during experimental prostatitis. Urol. Res. 21, 71–74.
Jepson, R. G., Mihaljevic, L., and Craig, J. (2000) Cranberries for treating urinary tract infec tions. Cochrane Database Syst. Rev. 2, CD001322.
Di Martino, P., Agniel, R., David, K., et al. (2006) Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: A double-blind randomized placebo-controlled cross-over trial. World J. Urol. 24, 21–27.
Lowe, F. C., and Fagelman, E. (2001) Cranberry juice and urinary tract infections: What is the evidence? Urology 57, 407–413.
McNaughton Collins, M., Fowler, F. J., Jr., Elliott, D. B., Albertsen, P. C., and Barry, M. J. (2000) Diagnosing and treating chronic prostatitis: Do urologists use the four-glass test? Urology 55, 403–407.
Shoskes, D. A., and Shahed, A. R. (2000) Detection of bacterial signal by 16S rRNA polymer-ase chain reaction in expressed prostatic secretions predicts response to antibiotic therapy in men with chronic pelvic pain syndrome. Tech. Urol. 6, 240–242.
John, H., Barghorn, A., Funke, G., et al. (2001) Noninflammatory chronic pelvic pain syn drome: Immunological study in blood, ejaculate and prostate tissue. Eur. Urol. 39, 72–78.
Shahed, A. R., and Shoskes, D. A. (2000) Oxidative stress in prostatic fluid of patients with chronic pelvic pain syndrome: correlation with gram positive bacterial growth and treatment response. J. Androl. 21, 669–675.
Basyigit, I., Yildiz, F., Ozkara, S. K., Yildirim, E., Boyaci, H., and Ilgazli, A. (2004) The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data. Ann. Pharmacother. 38, 1400–1405.
Anderson, D., Dobrzynska, M. M., Basaran, N., Basaran, A., and Yu, T. W. (1998) Flavonoids modulate comet assay responses to food mutagens in human lymphocytes and sperm. Mutat. Res. 402, 269–277.
Phillips, S. A., Olson, E. B., Lombard, J. H., and Morgan, B. J. (2006) Chronic intermittent hypoxia alters NE reactivity and mechanics of skeletal muscle resistance arteries. J. Appl. Physiol. 100, 1117–1123.
Gerber, G. S., Kuznetsov, D., Johnson, B. C., and Burstein, J. D. (2001) Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms. Urology 58, 960–964; discussion 964–965.
Buck, A. C. (2004) Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action. J. Urol. 172, 1792–1799.
Bent, S., Kane, C., Shinohara, K., et al. (2006) Saw palmetto for benign prostatic hyperplasia. N. Engl. J. Med. 354, 557–566.
Debruyne, F., Boyle, P., Calais Da Silva, F., et al. (2004) Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis. Eur. Urol. 45, 773–779; disucssion 779–780.
Kaplan, S. A., Volpe, M. A., and Te, A. E. (2004) A prospective, 1-year trial using saw pal metto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syn drome. J. Urol. 171, 284–288.
Buck, A. C., Rees, R. W., and Ebeling, L. (1989) Treatment of chronic prostatitis and prosta-todynia with pollen extract. Br. J. Urol. 64, 496–499.
Rugendorff, E. W., Weidner, W., Ebeling, L., and Buck, A. C. (1993) Results of treatment with pollen extract (Cernilton N) in chronic prostatitis and prostatodynia. Br. J. Urol. 71, 433–438.
Elist, J. (2006) Effects of pollen extract preparation Prostat/Poltit on lower urinary tract symp toms in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a rand omized, double-blind, placebo-controlled study. Urology 67, 60–63.
Hollman, P. C., and Katan, M. B. (1998) Bioavailability and health effects of dietary flavonols in man. Arch. Toxicol. Suppl. 20, 237–248.
Azuma, K., Ippoushi, K., Ito, H., Horie, H., and Terao, J. (2003) Enhancing effect of lipids and emulsifiers on the accumulation of quercetin metabolites in blood plasma after the short-term ingestion of onion by rats. Biosci. Biotechnol. Biochem. 67, 2548–2555.
Aherne, S. A., and O'Brien, N. M. (2000) Mechanism of protection by the flavonoids, quer-cetin and rutin, against tert-butylhydroperoxide- and menadione-induced DNA single strand breaks in Caco-2 cells. Free Radic. Biol. Med. 29, 507–514.
Chen, Z. Y., Chan, P. T., Ho, K. Y., Fung, K. P., and Wang, J. (1996) Antioxidant activity of natural flavonoids is governed by number and location of their aromatic hydroxyl groups. hem. Phys. Lipids 79, 157–163.
Guardia, T., Rotelli, A. E., Juarez, A. O., and Pelzer, L. E. (2001) Anti-inflammatory proper ties of plant flavonoids. Effects of rutin, quercetin and hesperidin on adjuvant arthritis in rat. Farmaco 56, 683–687.
Liu, J., Li, X., Yue, Y., Li, J., He, T., and He, Y. (2005) The inhibitory effect of quercetin on IL-6 production by LPS-stimulated neutrophils. Cell Mol. Immunol. 2, 455–460.
Sato, M., Miyazaki, T., Kambe, F., Maeda, K., and Seo, H. (1997) Quercetin, a bioflavonoid, inhibits the induction of interleukin 8 and monocyte chemoattractant protein-1 expression by tumor necrosis factor- alpha in cultured human synovial cells. J. Rheumatol. 24, 1680–1684.
Nair, M. P., Mahajan, S., Reynolds, J. L., et al. (2006) The flavonoid quercetin inhibits proin-flammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin. Vaccine Immunol. 13, 319–328.
Garcia-Mediavilla, V., Crespo, I., Collado, P. S., et al. (2007) The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur. J. Pharmacol. 557, 221–229.
Alexander, R. B., Ponniah, S., Hasday, J., Hebel, J. R. (1998) Elevated levels of proinflam-matory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syn drome. Urology 52, 744–749.
Murota, K., and Terao, J. (2003) Antioxidative flavonoid quercetin: implication of its intesti nal absorption and metabolism. Arch. Biochem. Biophys. 417, 12–17.
Shoskes, D. A. (1999) Use of the bioflavonoid quercetin in patients with longstanding chronic prostatitis. J. Am Neutraceutical Assoc. 2, 18–21.
Shoskes, D. A., Zeitlin, S. I., Shahed, A., and Rajfer, J. (1999) Quercetin in men with category III chronic prostatitis: A preliminary prospective, double-blind, placebo-controlled trial. Urology 54, 960–963.
Rajasekaran, M., Hellstrom, W. J., Naz, R. K., and Sikka, S. C. (1995) Oxidative stress and interleukins in seminal plasma during leukocytospermia. Fertil. Steril. 64, 166–171.
Shahed, A. R., and Shoskes, D. A. (2001) Correlation of beta-endorphin and prostaglandin E2 levels in prostatic fluid of patients with chronic prostatitis with diagnosis and treatment response. J. Urol. 166, 1738–1741.
Aziz, N. H., Farag, S. E., Mousa, L. A., and Abo-Zaid, M. A. (1998) Comparative antibacte rial and antifungal effects of some phenolic compounds. Microbios. 93, 43–54.
Plaper, A., Golob, M., Hafner, I., Oblak, M., Solmajer, T., and Jerala, R. (2003) Characterization of quercetin binding site on DNA gyrase. Biochem. Biophys. Res. Commun. 306, 530–536.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Shoskes, D.A. (2008). Phytotherapy and the Prostatitis Syndromes. In: Shoskes, D.A. (eds) Chronic Prostatitis/Chronic Pelvic Pain Syndrome. Current Clinical Urology. Humana Press. https://doi.org/10.1007/978-1-59745-472-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-59745-472-8_8
Publisher Name: Humana Press
Print ISBN: 978-1-934115-27-5
Online ISBN: 978-1-59745-472-8
eBook Packages: MedicineMedicine (R0)